img

Global Hyper Personalized Medicine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Hyper Personalized Medicine Market Research Report 2024

According to MRAResearch’s new survey, global Hyper Personalized Medicine market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hyper Personalized Medicine market research.
Key companies engaged in the Hyper Personalized Medicine industry include Danaher Corporation, lllumina, Inc., Decode Genetics, Inc., Dako A/SASURAGEN,INC., GE Healthcare, QIAGEN, Exagen lnc., Exact Sciences Corporation and Abbott, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Hyper Personalized Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Hyper Personalized Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hyper Personalized Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Danaher Corporation
lllumina, Inc.
Decode Genetics, Inc.
Dako A/SASURAGEN,INC.
GE Healthcare
QIAGEN
Exagen lnc.
Exact Sciences Corporation
Abbott
Segment by Type
Hyper Personalized Medicine Diagnostics
Hyper Personalized Medicine Therapeutics
Hyper Personalized Medical Care
Hyper Personalized Nutrition and Wellness

Segment by Application


Hospitals
Diagnostic Centers
Research and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hyper Personalized Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyper Personalized Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Hyper Personalized Medicine Diagnostics
1.2.3 Hyper Personalized Medicine Therapeutics
1.2.4 Hyper Personalized Medical Care
1.2.5 Hyper Personalized Nutrition and Wellness
1.3 Market by Application
1.3.1 Global Hyper Personalized Medicine Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Research and Academic Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hyper Personalized Medicine Market Perspective (2018-2033)
2.2 Hyper Personalized Medicine Growth Trends by Region
2.2.1 Global Hyper Personalized Medicine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hyper Personalized Medicine Historic Market Size by Region (2018-2023)
2.2.3 Hyper Personalized Medicine Forecasted Market Size by Region (2024-2033)
2.3 Hyper Personalized Medicine Market Dynamics
2.3.1 Hyper Personalized Medicine Industry Trends
2.3.2 Hyper Personalized Medicine Market Drivers
2.3.3 Hyper Personalized Medicine Market Challenges
2.3.4 Hyper Personalized Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hyper Personalized Medicine Players by Revenue
3.1.1 Global Top Hyper Personalized Medicine Players by Revenue (2018-2023)
3.1.2 Global Hyper Personalized Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Hyper Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hyper Personalized Medicine Revenue
3.4 Global Hyper Personalized Medicine Market Concentration Ratio
3.4.1 Global Hyper Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyper Personalized Medicine Revenue in 2022
3.5 Hyper Personalized Medicine Key Players Head office and Area Served
3.6 Key Players Hyper Personalized Medicine Product Solution and Service
3.7 Date of Enter into Hyper Personalized Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hyper Personalized Medicine Breakdown Data by Type
4.1 Global Hyper Personalized Medicine Historic Market Size by Type (2018-2023)
4.2 Global Hyper Personalized Medicine Forecasted Market Size by Type (2024-2033)
5 Hyper Personalized Medicine Breakdown Data by Application
5.1 Global Hyper Personalized Medicine Historic Market Size by Application (2018-2023)
5.2 Global Hyper Personalized Medicine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hyper Personalized Medicine Market Size (2018-2033)
6.2 North America Hyper Personalized Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Hyper Personalized Medicine Market Size by Country (2018-2023)
6.4 North America Hyper Personalized Medicine Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hyper Personalized Medicine Market Size (2018-2033)
7.2 Europe Hyper Personalized Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Hyper Personalized Medicine Market Size by Country (2018-2023)
7.4 Europe Hyper Personalized Medicine Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hyper Personalized Medicine Market Size (2018-2033)
8.2 Asia-Pacific Hyper Personalized Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Hyper Personalized Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Hyper Personalized Medicine Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hyper Personalized Medicine Market Size (2018-2033)
9.2 Latin America Hyper Personalized Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Hyper Personalized Medicine Market Size by Country (2018-2023)
9.4 Latin America Hyper Personalized Medicine Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hyper Personalized Medicine Market Size (2018-2033)
10.2 Middle East & Africa Hyper Personalized Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Hyper Personalized Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Hyper Personalized Medicine Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher Corporation
11.1.1 Danaher Corporation Company Detail
11.1.2 Danaher Corporation Business Overview
11.1.3 Danaher Corporation Hyper Personalized Medicine Introduction
11.1.4 Danaher Corporation Revenue in Hyper Personalized Medicine Business (2018-2023)
11.1.5 Danaher Corporation Recent Development
11.2 lllumina, Inc.
11.2.1 lllumina, Inc. Company Detail
11.2.2 lllumina, Inc. Business Overview
11.2.3 lllumina, Inc. Hyper Personalized Medicine Introduction
11.2.4 lllumina, Inc. Revenue in Hyper Personalized Medicine Business (2018-2023)
11.2.5 lllumina, Inc. Recent Development
11.3 Decode Genetics, Inc.
11.3.1 Decode Genetics, Inc. Company Detail
11.3.2 Decode Genetics, Inc. Business Overview
11.3.3 Decode Genetics, Inc. Hyper Personalized Medicine Introduction
11.3.4 Decode Genetics, Inc. Revenue in Hyper Personalized Medicine Business (2018-2023)
11.3.5 Decode Genetics, Inc. Recent Development
11.4 Dako A/SASURAGEN,INC.
11.4.1 Dako A/SASURAGEN,INC. Company Detail
11.4.2 Dako A/SASURAGEN,INC. Business Overview
11.4.3 Dako A/SASURAGEN,INC. Hyper Personalized Medicine Introduction
11.4.4 Dako A/SASURAGEN,INC. Revenue in Hyper Personalized Medicine Business (2018-2023)
11.4.5 Dako A/SASURAGEN,INC. Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Detail
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Hyper Personalized Medicine Introduction
11.5.4 GE Healthcare Revenue in Hyper Personalized Medicine Business (2018-2023)
11.5.5 GE Healthcare Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Hyper Personalized Medicine Introduction
11.6.4 QIAGEN Revenue in Hyper Personalized Medicine Business (2018-2023)
11.6.5 QIAGEN Recent Development
11.7 Exagen lnc.
11.7.1 Exagen lnc. Company Detail
11.7.2 Exagen lnc. Business Overview
11.7.3 Exagen lnc. Hyper Personalized Medicine Introduction
11.7.4 Exagen lnc. Revenue in Hyper Personalized Medicine Business (2018-2023)
11.7.5 Exagen lnc. Recent Development
11.8 Exact Sciences Corporation
11.8.1 Exact Sciences Corporation Company Detail
11.8.2 Exact Sciences Corporation Business Overview
11.8.3 Exact Sciences Corporation Hyper Personalized Medicine Introduction
11.8.4 Exact Sciences Corporation Revenue in Hyper Personalized Medicine Business (2018-2023)
11.8.5 Exact Sciences Corporation Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Hyper Personalized Medicine Introduction
11.9.4 Abbott Revenue in Hyper Personalized Medicine Business (2018-2023)
11.9.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hyper Personalized Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Hyper Personalized Medicine Diagnostics
Table 3. Key Players of Hyper Personalized Medicine Therapeutics
Table 4. Key Players of Hyper Personalized Medical Care
Table 5. Key Players of Hyper Personalized Nutrition and Wellness
Table 6. Global Hyper Personalized Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Hyper Personalized Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Hyper Personalized Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Hyper Personalized Medicine Market Share by Region (2018-2023)
Table 10. Global Hyper Personalized Medicine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Hyper Personalized Medicine Market Share by Region (2024-2033)
Table 12. Hyper Personalized Medicine Market Trends
Table 13. Hyper Personalized Medicine Market Drivers
Table 14. Hyper Personalized Medicine Market Challenges
Table 15. Hyper Personalized Medicine Market Restraints
Table 16. Global Hyper Personalized Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Hyper Personalized Medicine Market Share by Players (2018-2023)
Table 18. Global Top Hyper Personalized Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyper Personalized Medicine as of 2022)
Table 19. Ranking of Global Top Hyper Personalized Medicine Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Hyper Personalized Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hyper Personalized Medicine Product Solution and Service
Table 23. Date of Enter into Hyper Personalized Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hyper Personalized Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Hyper Personalized Medicine Revenue Market Share by Type (2018-2023)
Table 27. Global Hyper Personalized Medicine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Hyper Personalized Medicine Revenue Market Share by Type (2024-2033)
Table 29. Global Hyper Personalized Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Hyper Personalized Medicine Revenue Market Share by Application (2018-2023)
Table 31. Global Hyper Personalized Medicine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Hyper Personalized Medicine Revenue Market Share by Application (2024-2033)
Table 33. North America Hyper Personalized Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Hyper Personalized Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Hyper Personalized Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Hyper Personalized Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Hyper Personalized Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Hyper Personalized Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Hyper Personalized Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Hyper Personalized Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Hyper Personalized Medicine Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Hyper Personalized Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Hyper Personalized Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hyper Personalized Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Hyper Personalized Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Hyper Personalized Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Hyper Personalized Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 48. Danaher Corporation Company Detail
Table 49. Danaher Corporation Business Overview
Table 50. Danaher Corporation Hyper Personalized Medicine Product
Table 51. Danaher Corporation Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 52. Danaher Corporation Recent Development
Table 53. lllumina, Inc. Company Detail
Table 54. lllumina, Inc. Business Overview
Table 55. lllumina, Inc. Hyper Personalized Medicine Product
Table 56. lllumina, Inc. Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 57. lllumina, Inc. Recent Development
Table 58. Decode Genetics, Inc. Company Detail
Table 59. Decode Genetics, Inc. Business Overview
Table 60. Decode Genetics, Inc. Hyper Personalized Medicine Product
Table 61. Decode Genetics, Inc. Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 62. Decode Genetics, Inc. Recent Development
Table 63. Dako A/SASURAGEN,INC. Company Detail
Table 64. Dako A/SASURAGEN,INC. Business Overview
Table 65. Dako A/SASURAGEN,INC. Hyper Personalized Medicine Product
Table 66. Dako A/SASURAGEN,INC. Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 67. Dako A/SASURAGEN,INC. Recent Development
Table 68. GE Healthcare Company Detail
Table 69. GE Healthcare Business Overview
Table 70. GE Healthcare Hyper Personalized Medicine Product
Table 71. GE Healthcare Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 72. GE Healthcare Recent Development
Table 73. QIAGEN Company Detail
Table 74. QIAGEN Business Overview
Table 75. QIAGEN Hyper Personalized Medicine Product
Table 76. QIAGEN Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 77. QIAGEN Recent Development
Table 78. Exagen lnc. Company Detail
Table 79. Exagen lnc. Business Overview
Table 80. Exagen lnc. Hyper Personalized Medicine Product
Table 81. Exagen lnc. Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 82. Exagen lnc. Recent Development
Table 83. Exact Sciences Corporation Company Detail
Table 84. Exact Sciences Corporation Business Overview
Table 85. Exact Sciences Corporation Hyper Personalized Medicine Product
Table 86. Exact Sciences Corporation Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 87. Exact Sciences Corporation Recent Development
Table 88. Abbott Company Detail
Table 89. Abbott Business Overview
Table 90. Abbott Hyper Personalized Medicine Product
Table 91. Abbott Revenue in Hyper Personalized Medicine Business (2018-2023) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hyper Personalized Medicine Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Hyper Personalized Medicine Market Share by Type: 2022 VS 2033
Figure 3. Hyper Personalized Medicine Diagnostics Features
Figure 4. Hyper Personalized Medicine Therapeutics Features
Figure 5. Hyper Personalized Medical Care Features
Figure 6. Hyper Personalized Nutrition and Wellness Features
Figure 7. Global Hyper Personalized Medicine Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Hyper Personalized Medicine Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Research and Academic Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Hyper Personalized Medicine Report Years Considered
Figure 14. Global Hyper Personalized Medicine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Hyper Personalized Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Hyper Personalized Medicine Market Share by Region: 2022 VS 2033
Figure 17. Global Hyper Personalized Medicine Market Share by Players in 2022
Figure 18. Global Top Hyper Personalized Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyper Personalized Medicine as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Hyper Personalized Medicine Revenue in 2022
Figure 20. North America Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Hyper Personalized Medicine Market Share by Country (2018-2033)
Figure 22. United States Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Hyper Personalized Medicine Market Share by Country (2018-2033)
Figure 26. Germany Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Hyper Personalized Medicine Market Share by Region (2018-2033)
Figure 34. China Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Hyper Personalized Medicine Market Share by Country (2018-2033)
Figure 42. Mexico Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Hyper Personalized Medicine Market Share by Country (2018-2033)
Figure 46. Turkey Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Hyper Personalized Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Danaher Corporation Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 49. lllumina, Inc. Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 50. Decode Genetics, Inc. Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 51. Dako A/SASURAGEN,INC. Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 52. GE Healthcare Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 53. QIAGEN Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 54. Exagen lnc. Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 55. Exact Sciences Corporation Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 56. Abbott Revenue Growth Rate in Hyper Personalized Medicine Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed